← Open Payments lookup

ESMERALDA BARRAGAN: Open Payments

NPI 1417426842 · SPRING, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$465 in 24 payments from 9 companies in 2025. Trend: 2023 $588 · 2024 $833 · 2025 $465

Food & beverage: $465
CompanyPaymentsAmount
Novo Nordisk Inc6$122
Bayer Healthcare Pharmaceuticals Inc.5$107
AstraZeneca Pharmaceuticals LP4$83
Lilly USA, LLC4$67
Exact Sciences Corporation1$26
Abbott Laboratories1$18
Cranial Technologies, Inc1$14
SHIELD THERAPEUTICS INC1$14
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$14

Products named: Kerendia, Ozempic, Rybelsus, FARXIGA, MOUNJARO, Cologuard Collection Kit, JARDIANCE, FREESTYLE LIBRE 3.

Industry payments across TX — which companies pay providers there.